Nicotine Patches Help Reduce Seizures in Genetic Epilepsy

Source: Sleep medicine

Summary

Researchers studied the use of nicotine as a treatment for Sleep-Related Hypermotor Epilepsy (SHE), a type of epilepsy that can have a genetic cause. They focused on a patient with a specific genetic mutation in the CHRNA4 gene, which affects the nicotinic cholinergic receptor system. The study included a review of existing literature on nicotine's effectiveness in treating SHE related to these genetic mutations, analyzing data from various medical databases.

The key findings showed that nicotine patches helped reduce the number of seizures and improved sleep quality for the patient studied. In the broader review of 31 patients with similar conditions, 94% experienced a significant decrease in seizure frequency after starting nicotine treatment, and 47% became seizure-free. While some patients reported side effects, most were manageable, and the 7mg/24h nicotine patch had the lowest side effect rate.

This research is important because it suggests that nicotine could be a helpful treatment option for people with SHE due to genetic mutations, especially those who have not responded well to other medications. However, the study has limitations, including the need for more controlled trials to confirm these findings and better understand the long-term effects of nicotine treatment.

Original source